- Home
- CYBN vs COOK Comparison
CYBN vs COOK Comparison
Compare CYBN & COOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- COOK
- Stock Information
- Founded
- CYBN 2019
- COOK 1985
- Country
- CYBN Canada
- COOK United States
- Employees
- CYBN N/A
- COOK N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- COOK Wholesale Distributors
- Sector
- CYBN Health Care
- COOK Consumer Discretionary
- Exchange
- CYBN Nasdaq
- COOK Nasdaq
- Market Cap
- CYBN 176.5M
- COOK 184.8M
- IPO Year
- CYBN N/A
- COOK 2021
- Fundamental
- Price
- CYBN $6.08
- COOK $1.31
- Analyst Decision
- CYBN Strong Buy
- COOK Hold
- Analyst Count
- CYBN 3
- COOK 7
- Target Price
- CYBN $85.00
- COOK $2.07
- AVG Volume (30 Days)
- CYBN 625.2K
- COOK 620.1K
- Earning Date
- CYBN 11-12-2025
- COOK 11-05-2025
- Dividend Yield
- CYBN N/A
- COOK N/A
- EPS Growth
- CYBN N/A
- COOK N/A
- EPS
- CYBN N/A
- COOK N/A
- Revenue
- CYBN N/A
- COOK $579,453,000.00
- Revenue This Year
- CYBN N/A
- COOK N/A
- Revenue Next Year
- CYBN N/A
- COOK $2.21
- P/E Ratio
- CYBN N/A
- COOK N/A
- Revenue Growth
- CYBN N/A
- COOK N/A
- 52 Week Low
- CYBN $4.81
- COOK $1.20
- 52 Week High
- CYBN $13.88
- COOK $3.97
- Technical
- Relative Strength Index (RSI)
- CYBN 38.92
- COOK 43.17
- Support Level
- CYBN $6.16
- COOK $1.20
- Resistance Level
- CYBN $6.55
- COOK $1.31
- Average True Range (ATR)
- CYBN 0.49
- COOK 0.09
- MACD
- CYBN -0.06
- COOK 0.02
- Stochastic Oscillator
- CYBN 12.90
- COOK 35.00
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
About COOK Traeger Inc.
Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.